Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$304,384,314
-$605,429 QoQ
Shares Held
1,198,505
-3.9% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#151
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $1,455,266,466 across 11 Drug Manufacturers - General names. JNJ ranks #2 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,829,082 | $357,426,219 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,198,505 | $304,384,314 | |
| 3 | ABBV |
AbbVie Inc.
|
1,073,381 | $270,105,594 | |
| 4 | AMGN |
Amgen Inc
|
697,030 | $252,408,503 | |
| 5 | LLY |
ELI LILLY & Co
|
129,204 | $154,971,166 | |
| 6 | MRK |
Merck & Co., Inc.
|
517,507 | $66,499,649 | |
| 7 | PFE |
Pfizer Inc
|
906,089 | $21,818,623 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
335,197 | $19,314,051 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $304,384,314 | 1,198,505 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $304,989,743 | 1,247,708 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $290,304,907 | 1,402,778 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $280,506,898 | 1,512,819 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $239,299,219 | 1,566,607 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $276,211,661 | 1,665,531 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $241,694,873 | 1,671,241 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $254,214,446 | 1,568,644 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $241,417,295 | 1,651,733 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $237,937,375 | 1,504,124 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $238,787,747 | 1,523,464 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $231,915,332 | 1,489,023 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $269,607,583 | 1,628,852 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $247,969,930 | 1,599,806 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $263,926,228 | 1,494,063 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $236,253,682 | 1,446,215 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $263,876,425 | 1,486,544 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $309,664,231 | 1,747,245 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $294,780,810 | 1,723,159 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $238,532,108 | 1,476,979 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $241,000,452 | 1,462,914 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $209,060,102 | 1,272,042 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $194,007,204 | 1,232,731 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $170,159,120 | 1,142,928 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $151,061,230 | 1,074,175 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $152,529,891 | 1,163,196 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||